Evaluation of cardiovascular disease and fatty liver disease in type 2 diabetes subjects on ultrasonography. Int. Res. J. Pharm. [Internet]. 2024 Nov. 15 [cited 2026 Jun. 1];15(6):17-21. Available from: https://irjponline.org/index.php/irjp/article/view/88